Rznomics Highlights Early Clinical Activity of RZ-001 at ASNO 2026
SEONGNAM and SEOUL, South Korea, June 15, 2026 Rznomics Inc., a clinical-stage biopharmaceutical company focused on RNA-based gene therapies,...
Taspitimagene advec
Advertisement
Advertisement
